1.96

5.77% -0.12

Compugen Ltd (CGEN)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$2.08

Offen:

$2.08

24-Stunden-Volumen:

169.43K

Relative Volume:

0.81

Marktkapitalisierung:

$185.67M

Einnahmen:

$72.66M

Nettoeinkommen (Verlust:

$34.86M

KGV:

5.3552

EPS:

0.366

Netto-Cashflow:

$-62.91M

1W Leistung:

-7.98%

1M Leistung:

-18.67%

6M Leistung:

-32.18%

1J Leistung:

+0.51%

1-Tages-Spanne:

$1.93

$2.09

1-Wochen-Bereich:

$1.93

$2.13

52-Wochen-Spanne:

$1.43

$3.235

Compugen Ltd Stock (CGEN) Company Profile

Firmenname

Compugen Ltd

Sektor

Healthcare (1052)

Branche

Biotechnology (594)

Telefon

Adresse

Mitarbeiter

Twitter

@CompugenLtd

Nächster Verdiensttermin

2026-11-09

Neueste SEC-Einreichungen

CGEN's Discussions on Twitter

Compare CGEN vs VRTX, MRNA, REGN, ARGX, ONC

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
CGEN Compugen Ltd	1.96	185.67M	72.66M	34.86M	-62.91M	0.366
VRTX Vertex Pharmaceuticals Inc	499.74	126.66B	12.34B	4.34B	3.71B	16.87
MRNA Moderna Inc	218.01	87.04B	2.23B	-3.19B	-1.60B	-8.1462
REGN Regeneron Pharmaceuticals Inc	790.74	81.41B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	819.14	51.51B	4.16B	1.29B	734.26M	19.58
ONC Beone Medicines Ltd Adr	369.06	41.75B	5.76B	514.49M	1.10B	4.4813

Compugen Ltd Stock (CGEN) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2026-04-07	Eingeleitet	Lake Street	Buy
2026-01-07	Eingeleitet	H.C. Wainwright	Buy
2025-01-13	Eingeleitet	Oppenheimer	Outperform
2022-08-05	Herabstufung	Jefferies	Buy → Hold
2020-05-26	Fortgesetzt	JMP Securities	Mkt Outperform
2020-05-13	Eingeleitet	Stifel	Buy
2020-05-07	Eingeleitet	SVB Leerink	Outperform
2020-04-22	Eingeleitet	ROTH Capital	Buy
2020-03-24	Eingeleitet	SunTrust	Buy
2020-01-16	Eingeleitet	Cantor Fitzgerald	Overweight
2018-03-29	Eingeleitet	Oppenheimer	Outperform
2016-02-01	Fortgesetzt	Oppenheimer	Outperform
2015-10-15	Eingeleitet	FBR Capital	Outperform
2015-04-23	Fortgesetzt	Jefferies	Buy
2015-04-21	Eingeleitet	Oppenheimer	Outperform
2014-02-07	Eingeleitet	MLV & Co	Buy
2009-12-28	Bestätigt	Cantor Fitzgerald	Buy
2009-07-29	Eingeleitet	Cantor Fitzgerald	Buy

Alle ansehen

Compugen Ltd Aktie (CGEN) Neueste Nachrichten

Oct 12, 2026

Compugen Price Target Maintained With a $4.00/Share by HC Wainwright & Co. - Moomoo

Oct 12, 2026

CGEN Reiterated by HC Wainwright & Co. -- Price Target Maintained at $4.00 - GuruFocus

Oct 12, 2026

Oct 06, 2026

Stifel reiterates Compugen stock rating on ovarian trial update - Investing.com

Oct 06, 2026

Compugen to Participate in a Fireside Chat at the H.C. Wainwright 3rd Annual AI Based Drug Discovery & Development Conference - Yahoo Finance

Oct 06, 2026

An online conference on AI drug discovery will include Compugen. - Stock Titan

Oct 06, 2026

Oct 05, 2026

Compugen Highlights COM701 Ovarian Trial, Expands AI Platform Into Tumor Targets - Yahoo Finance

Oct 05, 2026

Compugen Highlights COM701 Ovarian Trial, Expands AI Platform Into Tumor Targets - TradingView

Oct 05, 2026

Compugen to Host Virtual KOL Event on COM701 in Ovarian Cancer & Unigen™ Platform Update on October 5, 2026 - Yahoo Finance

Sep 22, 2026

A Harvard cancer expert will discuss an ovarian cancer drug. Compugen's event is Oct. 5. - Stock Titan

Sep 22, 2026

Sep 18, 2026

Compugen to Participate in a Fireside Chat at the H.C. Wainwright 28th Annual Global Investment Conference - Eastern Progress

Sep 18, 2026

Sep 11, 2026

Compugen Shareholders Approve All Proposals at 2026 Annual Meeting - The Globe and Mail

Sep 11, 2026

Sep 10, 2026

Compugen Shareholders Approve All Proposals at 2026 Annual Meeting - TipRanks

Sep 10, 2026

All 2026 AGM proposals pass at Compugen (CGEN) - Stock Titan

Sep 10, 2026

Sep 08, 2026

Israel National Biotech Innovation Center Launches With Anat Cohen-Dayag as CEO of INBI Core - citybiz

Sep 08, 2026

Compugen to present at H.C. Wainwright Investme... - Pluang

Sep 08, 2026

A cancer treatment company will speak live Sept. 14. Compugen’s talk will be webcast. - Stock Titan

Sep 08, 2026

Compugen to Participate in a Fireside Chat at the H.C. Wainwright 28th Annual Global Investment Conference - Yahoo Finance

Sep 08, 2026

Aug 31, 2026

All You Need to Know About Compugen (CGEN) Rating Upgrade to Buy - Yahoo Finance

Aug 31, 2026

Aug 23, 2026

Compugen (CGEN) Reports Q1 Loss, Lags Revenue Estimates - Eastern Progress

Aug 23, 2026

Aug 22, 2026

Compugen (CGEN) Reports Q2 Loss, Misses Revenue Estimates - Eastern Progress

Aug 22, 2026

Aug 21, 2026

Are Medical Stocks Lagging Compugen (CGEN) This Year? - Yahoo Finance

Aug 21, 2026

Aug 18, 2026

Compugen (CGEN) Earnings Brief: The Bottom-Line Figure Outpaces Its Comparison in the Latest Session; Price Reaction: Shares Finish 1.28% Up on the DayCost Structure Review - dars.gov.et

Aug 18, 2026

Compugen (CGEN) Earnings Brief: The Bottom-Line Figure Outpaces Its Comparison in the Latest Session; Price Reaction: Shares Finish 1.28% Up on the DayQuarterly Financial Update - dars.gov.et

Aug 18, 2026

Compugen (CGEN) Earnings Brief: The Bottom-Line Figure Outpaces Its Comparison in the Latest Session; Price Reaction: Shares Finish 1.28% Up on the DayEarnings Surprise Stocks - vinanet.vn

Aug 18, 2026

Compugen (CGEN) Dips 2.49% to $2.35, Pressure Mounts Toward Support at $2.23Price Target - vinanet.vn

Aug 18, 2026

Compugen (CGEN) Dips 2.49% to $2.35, Pressure Mounts Toward Support at $2.23NAAIM Leverage - dars.gov.et

Aug 18, 2026

Aug 16, 2026

Analysts Have Just Cut Their Compugen Ltd. (NASDAQ:CGEN) Revenue Estimates By 14% - simplywall.st

Aug 16, 2026

Aug 15, 2026

CGEN Q2 2026 Earnings: Loss Narrower Than Expected as EPS Surprises PositivelyMargin Expansion Trends - vinanet.vn

Aug 15, 2026

CGEN Q2 2026 Earnings: Loss Narrower Than Expected as EPS Surprises PositivelyMargin Expansion Trends - vinanet.vn

Aug 15, 2026

Aug 14, 2026